Author

Garrett Ward

Scripps Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:mouse· 2 Assay:proteomics· 1 Assay:structural biology· 1

Frequent Co-Authors

Jiang ZhuiD· 3 shared Linling HeiD· 3 shared Yi-Nan ZhangiD· 3 shared Yi-Zong LeeiD· 3 shared Connor DesRoberts· 2 shared Joel D. AlleniD· 2 shared Keegan Braz GomesiD· 2 shared Maddy L. NewbyiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Jiang ZhuORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design

Linling He, Yi-Zong Lee, Yi-Nan Zhang, Maddy L. Newby, Benjamin M. Janus, Fabrizio G. Gonzalez, Garrett Ward, Connor DesRoberts, Shr-Hau Hung, Erick Giang, Joel D. Allen, Liudmila Kulakova, Eric A. Toth, Thomas R. Fuerst, Mansun Law, , Jiang Zhu

The paper designs, characterizes, and tests a soluble HCV E1E2 heterodimer and self-assembling nanoparticles for vaccine development.

Nature Communications · Feb 11, 2026Peer-reviewedMicrobiology

Rational design of next-generation filovirus vaccines through glycoprotein stabilization, nanoparticle display, and glycan modification

Yi-Zong Lee, Yi-Nan Zhang, Maddy L. Newby, Garrett Ward, Keegan Braz Gomes, Sarah Auclair, Connor DesRoberts, Joel D. Allen, Andrew B. Ward, Robyn L. Stanfield, Linling He, Max Crispin, Ian A. Wilson, Jiang Zhu

This study rationally designs and characterizes filovirus glycoproteins and nanoparticles in vitro and in vivo to aid vaccine development.

bioRxiv · Mar 2, 2025 · PreprintMicrobiology

A Universal, Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 Against Both Influenza A and B

Yi-Nan Zhang, Keegan Braz Gomes, Yi-Zong Lee, Garrett Ward, Bomin Xie, Sarah Auclair, Linling He, Jiang Zhu

This paper develops a single-component self-assembling nanoparticle vaccine targeting conserved M2e domains from both influenza A and B viruses, showing 100% protection against H1N1 and 70% against Yamagata lineage influenza B in mice.

Vaccines · Aug 28, 2024Peer-reviewedMicrobiology